Cargando…

Can we predict septic shock in patients with hospital-acquired pneumonia?

Hospital-acquired pneumonia is a serious and potentially life-threatening complication, with reported pneumonia-attributable mortality rates as high as 50%. Rapid diagnosis and immediate institution of adequate empirical antimicrobial treatment are of paramount importance in patient management. Neve...

Descripción completa

Detalles Bibliográficos
Autores principales: de Lange, Dylan W, Bonten, Marc JM
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2005
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1413995/
https://www.ncbi.nlm.nih.gov/pubmed/16356255
http://dx.doi.org/10.1186/cc3919
_version_ 1782127099855765504
author de Lange, Dylan W
Bonten, Marc JM
author_facet de Lange, Dylan W
Bonten, Marc JM
author_sort de Lange, Dylan W
collection PubMed
description Hospital-acquired pneumonia is a serious and potentially life-threatening complication, with reported pneumonia-attributable mortality rates as high as 50%. Rapid diagnosis and immediate institution of adequate empirical antimicrobial treatment are of paramount importance in patient management. Nevertheless, some patients deteriorate and develop respiratory insufficiency, septic shock and a multiorgan dysfunction syndrome. Early recognition of these patients might help in reducing morbidity and mortality. Elevated systemic levels of proinflammatory cytokines (IL-1β, IL-6, IL-8 and IL-10) at the time of diagnosis of hospital-acquired pneumonia appear to be indicative of subsequent progression to septic shock. Should this now become a part of patient management?
format Text
id pubmed-1413995
institution National Center for Biotechnology Information
language English
publishDate 2005
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-14139952006-03-28 Can we predict septic shock in patients with hospital-acquired pneumonia? de Lange, Dylan W Bonten, Marc JM Crit Care Commentary Hospital-acquired pneumonia is a serious and potentially life-threatening complication, with reported pneumonia-attributable mortality rates as high as 50%. Rapid diagnosis and immediate institution of adequate empirical antimicrobial treatment are of paramount importance in patient management. Nevertheless, some patients deteriorate and develop respiratory insufficiency, septic shock and a multiorgan dysfunction syndrome. Early recognition of these patients might help in reducing morbidity and mortality. Elevated systemic levels of proinflammatory cytokines (IL-1β, IL-6, IL-8 and IL-10) at the time of diagnosis of hospital-acquired pneumonia appear to be indicative of subsequent progression to septic shock. Should this now become a part of patient management? BioMed Central 2005 2005-11-11 /pmc/articles/PMC1413995/ /pubmed/16356255 http://dx.doi.org/10.1186/cc3919 Text en Copyright © 2005 BioMed Central Ltd
spellingShingle Commentary
de Lange, Dylan W
Bonten, Marc JM
Can we predict septic shock in patients with hospital-acquired pneumonia?
title Can we predict septic shock in patients with hospital-acquired pneumonia?
title_full Can we predict septic shock in patients with hospital-acquired pneumonia?
title_fullStr Can we predict septic shock in patients with hospital-acquired pneumonia?
title_full_unstemmed Can we predict septic shock in patients with hospital-acquired pneumonia?
title_short Can we predict septic shock in patients with hospital-acquired pneumonia?
title_sort can we predict septic shock in patients with hospital-acquired pneumonia?
topic Commentary
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1413995/
https://www.ncbi.nlm.nih.gov/pubmed/16356255
http://dx.doi.org/10.1186/cc3919
work_keys_str_mv AT delangedylanw canwepredictsepticshockinpatientswithhospitalacquiredpneumonia
AT bontenmarcjm canwepredictsepticshockinpatientswithhospitalacquiredpneumonia